|
Definitive Radiation for High-Risk Spine Metastases
RECRUITINGPhase 2Sponsored by Stony Brook University
Actively Recruiting
PhasePhase 2
SponsorStony Brook University
Started2023-12-14
Est. completion2026-05-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06165419
Summary
This study is looking at whether patients with cancer that has aggressively spread to the spine can be treated with stereotactic body radiation therapy only and avoid a large spine surgery
Eligibility
Age: 18 Years+Healthy volunteers accepted
Eligible patients must have: * Any pathologically proven solid tumor diagnosis not of central nervous system origin with radiographic or pathologic evidence of metastatic disease * Metastatic spine involvement documented by imaging * Involvement of maximum 3 contiguous vertebral bodies at the index site * Intact neurologic function, or only minor neurologic deficits with muscle strength greater or equal to 4 out of 5 with or without steroids * An evaluation by an radiation oncology and orthopedic spine/neurosurgery attending * ECOG Performance Status of 0-3 Patients are ineligible if they have: * An unstable spine defined as a Spinal Instability Neoplastic Score (SINS) greater than 12 * Had previous surgery or radiation to address the target spinal metastases * Radiosensitive tumors (e.g. small cell lung cancer, lymphoma, multiple myeloma, and germ-cell tumors)
Conditions11
Breast CancerCancerLung CancerMetastasisMetastatic Breast CancerMetastatic CancerMetastatic Lung CancerMetastatic TumorMetastatic Tumor of BoneMetastatic Tumor to the Spine
Locations1 site
Stony Brook University Hospital
Stony Brook, New York, 11794
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorStony Brook University
Started2023-12-14
Est. completion2026-05-31
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06165419